Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 234,254 | 273,865 | 146,073 | 176,385 | 143,467 |
| Receivables | 304 | 257 | 315 | 284 | 433 |
| TOTAL | $243,777 | $280,493 | $153,754 | $181,623 | $150,402 |
| Non-Current Assets | |||||
| PPE Net | 2,485 | 2,501 | 2,799 | 2,878 | 2,988 |
| Other Non-Current Assets | 7,454 | 7,881 | 8,299 | 8,709 | 7,793 |
| TOTAL | $9,939 | $10,382 | $11,098 | $11,587 | $10,781 |
| Total Assets | $253,716 | $290,875 | $164,852 | $193,210 | $161,183 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,916 | 8,326 | 8,569 | 9,247 | 7,893 |
| Accrued Expenses | 19,666 | 17,224 | 14,605 | 12,472 | 9,265 |
| TOTAL | $32,640 | $27,576 | $25,426 | $24,201 | $20,105 |
| Non-Current Liabilities | |||||
| Long Term Debt | 203,265 | 202,069 | 170,819 | 169,800 | 109,141 |
| Deferred Revenues | 149 | 166 | 440 | 717 | 1,228 |
| TOTAL | $205,943 | $205,242 | $174,476 | $173,931 | $113,728 |
| Total Liabilities | $238,583 | $232,818 | $199,902 | $198,132 | $133,833 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,616 | 43,572 | 43,551 | 39,058 | 39,037 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -421,289 | -372,373 | -331,458 | -296,133 | -258,401 |
| TOTAL | $15,133 | $58,057 | $-35,050 | $-4,922 | $27,350 |
| Total Liabilities And Equity | $253,716 | $290,875 | $164,852 | $193,210 | $161,183 |